XML 38 R27.htm IDEA: XBRL DOCUMENT v3.26.1

Equity (Tables)

3 Months Ended

Mar. 31, 2026

Stockholders' Equity Note [Abstract]

Schedule of stock sale activity

The following table summarizes the terms of the Company’s at-the-market (“ATM”) common stock offering program as of March 31, 2026. There was no activity for the ATM common stock offering program during the three months ended March 31, 2026, except for the shares sold on a forward basis, as discussed below.

ATM Common Stock Offering Program

Date

Maximum Aggregate Offering Price (in thousands)

2025 $750 million ATM(1)

February 13, 2025

$

750,000

(1)The ATM common stock offering program was originally implemented on February 17, 2022, and had an initial maximum aggregate offering price of $750 million. On February 13, 2025, following the filing of a new shelf registration statement, the Company carried forward the ATM common stock offering program to the new registration statement, at which time the remaining maximum aggregate offering price (that is, the amount carried forward) was less than $750 million.

Schedule of Forward Contracts Indexed to Issuer's Equity

The following table summarizes the activity for shares sold on a forward basis under the ATM common stock offering program and shares settled during the three months ended March 31, 2026.

Forward Sale Agreements						Shares						Gross Sales (in thousands)						Weighted Average Gross Sales Price Per Share						Weighted Average Net Sales Price Per Share						Sales Commissions Per Share(1)
Forward Sale Agreements Outstanding at December 31, 2025						—						$	—
New forward sale agreements						160,441						6,145						$	38.30					$	37.92					$	0.38
Forward sale agreements settled						—						—
Forward Sale Agreements Outstanding at March 31, 2026						160,441						$	6,145

(1)Upon a forward sale, the equity distribution agent typically earns a sales commission of 1% of the gross sales price.

Schedule of activity related to unvested restricted stock awards

The following table summarizes activity related to the Company’s unvested restricted shares of common stock during the three months ended March 31, 2026.

Unvested Restricted Shares of Common Stock						Shares						Weighted Average Grant Date Fair Value per Share
Balance at December 31, 2025						110,832						$	35.99
Granted						39,540						$	37.93
Vested(1)						(44,498)						$	37.48
Forfeited						(7,113)						$	35.74
Balance at March 31, 2026						98,761						$	36.11

(1)The Company repurchased and retired 16,166 restricted shares of common stock that vested during the three months ended March 31, 2026.

Schedule of vested restricted shares of common stock activity

The following table summarizes the fair value at vesting for the restricted shares of common stock that vested during the three months ended March 31, 2026 and 2025.

						Three months ended March 31,
Vested Restricted Shares of Common Stock						2026						2025
Vested restricted shares of common stock						44,498						51,100
Fair value of vested restricted shares of common stock (in thousands)						$	1,636					$	1,728

X

- Definition

Tabular disclosure of sales of stock or previously unissued stock under a stock offering program. Does not include sales of stock by subsidiary or equity method investee.

+ References

No definition available.

+ Details

Name:	stag_ScheduleOfStockSalesTableTextBlock
Namespace Prefix:	stag_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Vested Restricted Stock Units Activity [Table Text Block]

+ References

No definition available.

+ Details

Name:	stag_ScheduleofVestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	stag_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of freestanding forward contracts issued by an entity that are indexed to, and potentially settled in an entity's own stock. The disclosure may include, but not be limited to: (i) the forward rate and the number of shares to which the contract is indexed, (ii) the settlement date or dates of the contract, (iii) the issuer's accounting for the contract, (iv) settlement alternatives (if applicable) including who controls the settlement alternatives and the maximum number of shares that could be required to be issued to net share settle the contract (if applicable), (v) the fact that a potentially infinite number of shares may be required to be issued to settle the contract, if a contract does not have a stated fixed or determinable maximum number of shares, and (vi) the contract's current fair value for each settlement alternative and how changes in the price of the issuer's equity instruments affect those settlement amounts.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

+ Details

Name:	us-gaap_ScheduleOfForwardContractsIndexedToIssuersEquityTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in restricted stock units (RSUs).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration